-
Company Profile
![]()
Taisho Pharmaceutical Holdings Co Ltd – Company Profile
Taisho Pharmaceutical Holdings Co Ltd (Taisho Pharmaceutical), a subsidiary of Otemon Co Ltd, develops, manufactures and markets self-medication drugs and prescription pharmaceuticals. The company’s self-medication products comprise over the counter (OTC) products, quasi-drugs and health food products. Its prescription pharmaceuticals portfolio includes ethical drugs in the fields of infectious diseases, orthopedic disorders, central nervous system (CNS) diseases and metabolic diseases. Taisho Pharmaceutical provide its products under Pabron, Lipovitan D, Riup, Livita, Colac, Zosyn, Clarith, Palux, Edirol, Geninax, and Lorcam brand...
Add to Basket -
Product Insights
![]()
Net Present Value Model: Palux
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Palux Drug Details Alprostadil (Palux) belongs...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.